Cargando…
Vascular Disrupting Agent Arsenic Trioxide Enhances Thermoradiotherapy of Solid Tumors
Our previous studies demonstrated arsenic trioxide- (ATO-) induced selective tumor vascular disruption and augmentation of thermal or radiotherapy effect against solid tumors. These results suggested that a trimodality approach of radiation, ATO, and local hyperthermia may have potent therapeutic ef...
Autores principales: | Griffin, Robert J., Williams, Brent W., Koonce, Nathan A., Bischof, John C., Song, Chang W., Asur, Rajalakshmi, Upreti, Meenakshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261488/ https://www.ncbi.nlm.nih.gov/pubmed/22272199 http://dx.doi.org/10.1155/2012/934918 |
Ejemplares similares
-
Acidification-induced sensitization to thermoradiotherapy in breast cancer
por: Leeper, DB, et al.
Publicado: (2001) -
Hypoxia Alleviating PdTe Nanoenzymes for Thermoradiotherapy
por: Li, Yang, et al.
Publicado: (2022) -
Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation
por: Bodis, Stephan, et al.
Publicado: (2022) -
Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers
por: Akhtar, Anam, et al.
Publicado: (2017) -
Comparison of Optical and Power Doppler Ultrasound Imaging for Non-Invasive Evaluation of Arsenic Trioxide as a Vascular Disrupting Agent in Tumors
por: Alhasan, Mustafa K., et al.
Publicado: (2012)